— Know what they know.
Not Investment Advice
Also trades as: AUSA.CN (CNQ)

AUSAF OTC

Australis Capital Inc.
1W: +0.0% 1M: +0.0% 3M: -50.0% YTD: -90.0% 1Y: -90.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2783 mcap · 266M float · 0.0001% daily turnover · Short 81% of daily vol

Income Trends

Revenue
$8M +955.8% ▲
Gross Profit
$4M +2054.2% ▲
Operating Income
-$19M -38.1% ▼
Net Income
-$50M -98.3% ▼
EPS (Diluted)
$-0.16 -14.3% ▼
EBITDA
-$14M +42.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$0$130K$221K$717K$8M
YoY Growth+0.0%+0.0%+70.7%+223.8%+955.8%
Cost of Revenue$0$2K$221K$920K$4M
Gross Profit$0$127K$222-$203K$4M
Gross Margin—98.2%0.1%-28.3%52.4%
R&D Expenses$0-$28$19$120K$0
SG&A Expenses$1K$4M$14M$13M$24M
Operating Expenses$1K$4M$15M$14M$25M
Operating Income-$1K-$4M-$14M-$14M-$19M
Operating Margin—-3309.2%-6500.8%-1957.0%-256.0%
Interest Expense$91K$45K$197K$125K$0
Income Before Tax-$43K-$4M-$23M-$26M-$51M
Tax Expense$43K$0$0-$78K$310K
Net Income-$43K-$4M-$23M-$25M-$50M
Net Margin—-3214.4%-10539.0%-3522.4%-661.5%
EPS (Diluted)$-0.00$-0.04$-0.14$-0.14$-0.16
EBITDA$48K-$4M-$23M-$25M-$14M
Shares Outstanding120M94M162M177M247M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms